Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 512217 | NSE Symbol : | ISIN : INE730E01016 | Industry : Trading |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
15-Apr-2025	15-Apr-2025	Change in Auditors	Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 15th April, 2025) which commenced at 03:00 P.M. and concluded at 03:30 P.M. have inter alia approved the following: 1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as internal auditors of the company for the financial year 2024-2025. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.
07-Feb-2025	14-Feb-2025	Quarterly Results	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited(hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Friday the 14th day of February 2025 at 01:30 P.M. inter alia to: - Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 31st December 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 14th February, 2025) which commenced at 01:30 P.M. and concluded at 05:00 P.M. have inter alia approved the following: The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 31st December, 2024 along with the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige (As per BSE Announcement Dated on 14/02/2025)
07-Nov-2024	14-Nov-2024	Quarterly Results	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter and half year ended 30th September 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Outcome of the Board Meeting. (As Per BSE Announcement dated on 14.11.2024)
02-Sep-2024	05-Sep-2024	AGM	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2024 inter alia to consider and approve ? To consider and approve the Directors Report along with all necessary annexures thereof for the Financial Year ended March 31 2024; ? To consider and fix day date time for holding the 22nd Annual General Meeting of the company and approve the notice of the same; ? To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting; ? To appoint scrutinizer to conduct e-voting and poll process of 22nd Annual General Meeting of the company; ? To consider and recommend the re-appointment of M/s. Harjeet Parvesh and Company Chartered Accountants as the statutory auditors of the company. ? To recommend the appointment of Mr. Hitendra Shamji Hirani (DIN: 10427309) as a Director of the company. ? To recommend the appointment of Mr. Jay Hitendra Hirani (DIN: 10435245) as a Director of the company. ? To consider and discuss any other routine matter or business of the company. Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith outcome of meeting of Board of Directors held today (i.e. 05th September, 2024) which commenced at 04:00 P.M. and concluded at 07:30 P.M. Thanking You. (As Per BSE Announcement Dated on: 05/09/2024)
07-Aug-2024	14-Aug-2024	Quarterly Results	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th June 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. PURSUANT TO REGULATION 30 OF SEBI (LODR) REGULATIONS, 2015, WE ARE PLEASED TO INFORM YOU THAT THE BOARD OF DIRECTORS AT THEIR MEETING HELD TODAY I.E. 14TH AUGUST 2024 WHICH COMMENCED AT 12:30 P.M. AND CONCLUDED AT 01:30 P.M. HAVE INTER-ALIA APPROVED THE FOLLOWING 1. THE BOARD CONSIDERED AND APPROVED THE UN-AUDITED STANDALONE FINANCIAL RESULTS OF THE COMPANY FOR THE QUARTER ENDED 30TH JUNE 2024 ALONG WITH THE LIMITED REVIEW REPORT DULY SIGNED BY THE AUDITORS OF THE COMPANY Read less.. (As Per BSE Announcement Dated on 14.08.2024)
22-May-2024	29-May-2024	Accounts	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve - Consider approve and take on record the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 29th May, 2024) which commenced at 04:00 P.M. and concluded at 05:30 P.M. have inter alia approved the following: ? The Board considered and approved the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March, 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the same on record and oblige. Thanking You. Read less.. (As Per BSE Announcement Dated on 29.05.2024)
03-May-2024	03-May-2024	Change in Auditors	Dear Sir/Madam, Please find the attached outcome of Board Meeting held today i.e. 03rd May, 2024 which commenced at 01:00 P.M. and concluded at 01:30 P.M. Kindly take the same on record and oblige. Thanking You. Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 03rd May, 2024) which commenced at 01:00 P.M. and concluded at 01:30 P.M. have inter alia approved the following: 1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as internal auditors of the company for the financial year 2023-2024. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. (As Per BSE Announcement Dated on 03.05.2024)
05-Feb-2024	13-Feb-2024	Quarterly Results	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Dear Sir/Madam With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Tuesday the 13th day of February 2024 at 03:00 P.M. inter alia to: - Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 31st December 2023 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. Dear Sir/Madam, Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 13th February, 2024) which commenced at 03:00 P.M. and concluded at 04:00 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 31st December, 2023 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige. Thanking You. (As per BSE Announcement Dated on 13/02/2024)
01-Nov-2023	08-Nov-2023	Quarterly Results	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Dear Sir/Madam With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Wednesday the 08th day of November 2023 at 04:00 P.M. inter alia to: - Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter and half year ended 30th September 2023 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. Dear Sir/Madam, Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 08th November, 2023) which commenced at 04:00 P.M. and concluded at 05:30 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter and half year ended 30th September, 2023 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige. Thanking You. (As Per BSE Announcement Dated on 08/11/2023) Dear Sir/Madam, With reference to the captioned subject, please find the attached revised outcome of Board Meeting. You are requested to kindly take the same on record and oblige. Thanking You. (As Per BSE Announcement Dated on 09/11/2023)
31-Aug-2023	04-Sep-2023	Change in Auditors	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2023 inter alia to consider and approve ? To consider and approve the Directors Report along with all necessary annexures thereof for the Financial Year ended March 31 2023; ? To consider and fix day date time for holding the 21st Annual General Meeting of the company and approve the notice of the same; ? To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting; ? To appoint scrutinizer to conduct e-voting and poll process of 21st Annual General Meeting of the company; ? To consider and recommend the re-appointment of M/s. Harjeet Parvesh and Company Chartered Accountants as the statutory auditors of the company. ? To consider and recommend the regularisation of appointment of Mr. Dinesh Kumar (DIN: 01149388) as an Independent Director of the company. ? To consider and discuss any other routine matter or business of the company. Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith outcome of meeting of Board of Directors held today (i.e. 04th September, 2023) which commenced at 03:30 P.M. and concluded at 08:30 P.M. Thanking You. (As per BSE Announcement Dated on 04/09/2023)
07-Aug-2023	14-Aug-2023	Quarterly Results	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Dear Sir/Madam With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Monday the 14th day of August 2023 at 04:00 P.M. inter alia to: - Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th June 2023 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 14th August, 2023) which commenced at 04:00 P.M. and concluded at 06:00 P.M. have inter alia approved the following: The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 30th June, 2023 alongwith the Limited Review Report duly signed by the Auditors of the company. The Board considered and approved the appointment of Mr. Dinesh Kumar (DIN: 01149388) as an Additional Independent Director of the company with effect from 14th August, 2023. You are requested to kindly take the same on record and oblige. Thanking You. (As Per BSE Announcement dated on 14.08.2023)
20-Jul-2023	20-Jul-2023	Change in Auditors	Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the outcome of meeting of the Board of Directors held today (i.e. 20th July, 2023) which commenced at 11:30 A.M. and concluded at 01:00 P.M. You are requested to kindly take the same on record and oblige. Dear Sir/Madam, The outcome of the Board Meeting held on 20th July, 2023 was submitted with the stock exchange on the same day i.e. on 20th July, 2023 itself. However, since inadvertently the details required as per SEBI circular number CIR/CFD/4/2015 dated 09th September, 2015 could not be attached with the said outcome, therefore, the outcome of the said meeting is being submitted afresh for the information of the stock exchange and general public. You are requested to take the same on record and oblige. Thanking You. (As Per BSE Announcement dated on 24.07.2023)
22-May-2023	30-May-2023	Accounts	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Tuesday the 30th day of May 2023 at 04:30 P.M. inter alia to: - Consider approve and take on record the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March 2023 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 30th May, 2023) which commenced at 04:30 P.M. and concluded at 06:30 P.M. have inter alia approved the following: The Board considered and approved the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March, 2023 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the same on record and oblige. (As Per BSE Announcement dated on 30.05.2023)
16-May-2023	16-May-2023	Change in Directors	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 16th May, 2023) which commenced at 11:00 A.M. and concluded at 04:30 P.M. have inter alia approved the following: 1. To appoint Ms. Sakshi Laller (DIN: 10163397) as a Whole Time Director. 2. T appoint Mr. Vishwambhar Dayal Gupta (DIN: 00152580) as an Additional Director. 3. To appoint Mr. Bharat Singh (PAN: CCOPS5076E) as a Chief Financial Officer (CFO). 4. To accept the resignation of Mr. Ramandeep Singh (DIN: 07896086). 5. To accept the resignation of Ms. Simmi Chhabra (DIN: 07870398) as an Independent Director. 6. To accept the resignation of Mr. Gursimran Singh (PAN: CAYPS2870L) as a Chief Financial Officer (CFO) (Key Managerial Personnel (KMP)). 7. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as internal auditors of the company. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 16th May, 2023) which commenced at 11:00 A.M. and concluded at 04:30 P.M. have inter alia approved the following: 4. To accept the resignation of Mr. Ramandeep Singh (DIN: 07896086) as a Whole Time Director of the company with effect from 16th May, 2023. 5. To accept the resignation of Ms. Simmi Chhabra (DIN: 07870398) as an Independent Director of the company with effect from 16th May, 2023. 6. To accept the resignation of Mr. Gursimran Singh (PAN: CAYPS2870L) as a Chief Financial Officer (CFO) (Key Managerial Personnel (KMP)) of the company with effect from 16th May, 2023. You are requested to kindly take the same on your record and acknowledge receipt. With reference to Regulation 6(1) and Regulation 30 read with Clause 7 of Para A of Schedule III of the SEBI (LODR) Regulations, 2015 we do hereby inform that the Board of Directors of the company at their meeting held on Tuesday, 16th May, 2023 have appointed Ms. Sakshi Laller as a Whole Time Director (Promoter, Executive Director, Women Director), Mr. Vishwambhar Dayal Gupta as an Additional Director (Promoter, Non-Executive Director) and Mr. Bharat Singh as a Chief Financial Officer (CFO) (Key Managerial Personnel (KMP)) with effect from 16th May, 2023. Further Mr. Ramandeep Singh and Ms. Simmi Chhabra have tendered their resignation from the directorship of the company and Mr. Gursimran Singh has tendered his resignation as a Chief Financial Officer (CFO) (Key Managerial Personnel (KMP)) of the company with effect from 16th May, 2023. You are requested to kindly take the same on record and acknowledge receipt. (As Per BSE Announcement dated on 17.05.2023)
03-Feb-2023	13-Feb-2023	Quarterly Results	PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Dear Sir / Madam With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Monday the 13th day of February 2023 at 03:30 P.M. inter alia to: - Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 31st December 2022 as per Regulation 33 of the Listing Regulations. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 13th August, 2022) which commenced at 03:30 P.M. and concluded at 05:00 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 31st December, 2022 alongwith Limited Review Report duly signed by the Auditors of the company. Kindly take on record the same and oblige. Thanking You. (As Per BSE Announcement Dated on 13/02/2023) Dear Sir/Madam, With respect to the captioned subject it is hereby informed that a meeting of Board of Directors of the company was held on 13th February, 2023 for the approval of Unaudited Standalone Financial Results of the company for the quarter ended 31st December, 2022 alongwith Limited Review Report duly signed by the Auditors of the company. Whereas, in the outcome of Board Meeting filed by the company the date of Board Meeting has been inadvertently mentioned as 13th August, 2022 in place of 13th February, 2023. Therefore, the date shall be read as 13th February, 2023 instead of 13th August, 2022. Further the other details and information provided by the company remains the same. Kindly take on record the same and oblige. Thanking You. (As per BSE Announcement Dated on 14/02/2023)

1 2 3

LOGIN HERE

Prism Medico & Pharmacy Ltd

Board Meeting